PRIVIUM FUND MANAGEMENT (UK) LTD TScan Therapeutics, Inc. Transaction History

PRIVIUM FUND MANAGEMENT (UK) LTD portfolio value:

$48,000
portfolio value

TScan Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 15.82K shares 48K $3.05 15.82K